Maitake for Integrative Cancer Care

Recruiting now · Phase 2

Conditions studied: Cancer

In brief

Maitake is an edible mushroom that is used for both its nutritional and medicinal properties. Human and animal studies have shown Maitake may help improve immune function; however, its effectiveness in people with cancer is not clear. The investigators aim to measure if Maitake has any immunomodulatory effects when given alongside conventional systemic cancer therapy.

Key facts

Study ID

NCT06323473

Run by

The Canadian College of Naturopathic Medicine

People needed

40

Starts

2024-10-15

Expected to finish

2026-05-15

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (≥18 years of age)
• Confirmed cancer diagnosis through biopsy or radiologic imaging
• Undergoing systemic treatment with either chemotherapy or CD4/6 inhibitors
• Currently receiving cancer treatment in Ontario, Canada

You may not qualify if…

• Hematologic cancers
• Previously received any mushroom supplement within 6 months prior to enrolment
• Allergy to mushrooms or mushroom products
• Diagnosis of diabetes
• Currently taking hypoglycemic or anticoagulant medications
• Currently receiving immune checkpoint inhibitors
• Unable to attend in in-person visits in either Ottawa or Toronto
• Any reason which, under the discretion of the Qualified Investigator or delegate, would preclude the patient from participating

Where it is running

• The Centre for Health Innovation — Ottawa, Ontario, Canada (enrolling)
• Canadian College of Naturopathic Medicine - Integrative Cancer Centre — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.